Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Publishing timestamp: 2024-04-20 08:00:01
Summary
A Morgan Stanley survey found that people taking GLP-1 medications are spending less on eating out and ordering takeout, which could impact the bottom lines of some food and restaurant companies. The rising demand for these medications is expected to continue, with the market for GLP-1s projected to be worth $105 billion by 2030. Some companies, like healthier fast-casual restaurants and coffee chains, are better positioned to manage the impact of GLP-1s, while others, like fast-food chains and packaged food companies, may face more pressure.
Sentiment: MIXED
Tickers: CAVA, SBUX, PTLO, SG, DEO, VITL, JACK, SMPL, WEN, CMG, DGE-GB, NOVO.B-DK, HSY, SAM, MS, STZ, NVO, BRBR, SHAK, TAP, LLY, WING,
Keywords: starbucks corp, cava group inc, wendys co, sweetgreen inc, health care industry, molson coors beverage co, novo nordisk a/s, diageo plc, vital farms inc, pharmaceuticals, breaking news, morgan stanley, business, chipotle mexican grill inc, boston beer co inc, lifestyle, eli lilly and co, simply good foods co, bellring brands inc, biotechnology, constellation brands inc, business news, wingstop inc, shake shack inc, portillos inc, hershey co, jack in the box inc, biotech and pharmaceuticals,